Related references
Note: Only part of the references are listed.Neonatal lethal Costello syndrome and unusual dinucleotide deletion/insertion mutations in HRAS predicting p.Gly12Val
Emma M. M. Burkitt-Wright et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2012)
IDH Mutation Detection in Formalin-Fixed Paraffin-Embedded Gliomas Using Multiplex PCR and Single-Base Extension
Marco Perizzolo et al.
BRAIN PATHOLOGY (2012)
Significance of IDH mutations varies with tumor histology, grade, and genetics in Japanese glioma patients
Akitake Mukasa et al.
CANCER SCIENCE (2012)
Identification of additional IDH mutations associated with oncometabolite R(-)-2-hydroxyglutarate production
P. S. Ward et al.
ONCOGENE (2012)
Oncometabolite 2-Hydroxyglutarate Is a Competitive Inhibitor of α-Ketoglutarate-Dependent Dioxygenases
Wei Xu et al.
CANCER CELL (2011)
IDH1 mutations in gliomas: First series from a tertiary care centre in India with comprehensive review of literature
Prerana Jha et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2011)
Isocitrate dehydrogenase mutations in diffuse gliomas: clinical and aetiological implications
R. Gupta et al.
JOURNAL OF CLINICAL PATHOLOGY (2011)
Diagnostic Testing for IDH1 and IDH2 Variants in Acute Myeloid Leukemia An Algorithmic Approach Using High-Resolution Melting Curve Analysis
Keyur P. Patel et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2011)
Some novel features of IDH1-mutated acute myeloid leukemia revealed in Chinese patients
Yiqun Zhang et al.
LEUKEMIA RESEARCH (2011)
Scientific correspondence
S. Pusch et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2011)
Rapid and sensitive assessment of the IDH1 and IDH2 mutation status in cerebral gliomas based on DNA pyrosequencing
Joerg Felsberg et al.
ACTA NEUROPATHOLOGICA (2010)
Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas
Christian Hartmann et al.
ACTA NEUROPATHOLOGICA (2010)
Absence of IDH mutation identifies a novel radiologic and molecular subtype of WHO grade II gliomas with dismal prognosis
Philippe Metellus et al.
ACTA NEUROPATHOLOGICA (2010)
IDH1 and IDH2: Not Your Typical Oncogenes
Zachary J. Reitman et al.
CANCER CELL (2010)
Detection of IDH1 and IDH2 Mutations by Fluorescence Melting Curve Analysis as a Diagnostic Tool for Brain Biopsies
Craig Horbinski et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2010)
A Pyrosequencing-Based Assay for the Rapid Detection of IDH1 Mutations in Clinical Samples
Prashanth Setty et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2010)
Prognostic Value of IDH1 Mutations Identified with PCR-RFLP Assay in Glioblastoma Patients
Mateusz Bujko et al.
MOLECULAR DIAGNOSIS & THERAPY (2010)
IDH1 or IDH2 mutations predict longer survival and response to temozolomide in low-grade gliomas
C. Houillier et al.
NEUROLOGY (2010)
Monoclonal antibody specific for IDH1 R132H mutation
David Capper et al.
ACTA NEUROPATHOLOGICA (2009)
A monoclonal antibody IMab-1 specifically recognizes IDH1R132H, the most common glioma-derived mutation
Yukinari Kato et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
Lenny Dang et al.
NATURE (2009)
IDH1 mutations are present in the majority of common adult gliomas but rare in primary glioblastomas
Koichi Ichimura et al.
NEURO-ONCOLOGY (2009)
IDH1 and IDH2 Mutations in Gliomas
Hai Yan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Glioma-Derived Mutations in IDH1 Dominantly Inhibit IDH1 Catalytic Activity and Induce HIF-1α
Shimin Zhao et al.
SCIENCE (2009)
Analysis of the IDH1 codon 132 mutation in brain tumors
Joerg Balss et al.
ACTA NEUROPATHOLOGICA (2008)
An integrated genomic analysis of human glioblastoma Multiforme
D. Williams Parsons et al.
SCIENCE (2008)
Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas
JS Smith et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)